http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005102355-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f967e22aa5c9a5786302815407df91a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e72c93a365e9ae2a3acf0d9d87c6b12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bf1445f3f1f2c8499e9c119a23d6bf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd89d77edade2f51432063328b1932e6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-592 |
| filingDate | 2005-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21fd80289a8967bb0728ab22c9a2b5a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aad37de2d6e96abbeaba74287d0a27ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6fbdf311ca38cd681db3ce52f730db |
| publicationDate | 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2005102355-A1 |
| titleOfInvention | METHODS OF TREATING VARIOUS VITAMIN D METABOLISM CONDITIONS WITH 1α-HYDROXYVITAMIN D2 |
| abstract | The present invention provides a method of increasing or maintaining blood concentrations of 1,25-dihydroxyvitamin D in a patient by administering an amount of lahydroxyvitamin D2. The invention also provides a method of concurrently lowering or maintaining plasma intact parathyroid hormone levels, increasing or maintaining serum calcium levels, maintaining serum phosphorous levels, or increasing or maintaining serum 1,25-dihydroxyvitamin D levels in a human patient by administering to the patient an amount of la-hydroxyvitamin D2. The invention also provides a method of reducing the risk of over suppression of plasma intact parathyroid hormone levels in a patient undergoing treatment for elevated levels of plasma intact parathyroid hormone, by administering lα-hydroxyvitamin D2 in an amount sufficient to decrease elevated intact parathyroid hormone levels while avoiding an abnormally low bone turnover rate. |
| priorityDate | 2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.